Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Myron Levin to Viral Vaccines

This is a "connection" page, showing publications Myron Levin has written about Viral Vaccines.

 
Connection Strength
 
 
 
0.914
 
  1. Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis. 2003 Nov 01; 188(9):1336-44.
    View in: PubMed
    Score: 0.197
  2. Hayward AR, Buda K, Jones M, White CJ, Levin MJ. Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine. Viral Immunol. 1996; 9(4):241-5.
    View in: PubMed
    Score: 0.115
  3. Levin MJ, Murray M, Zerbe GO, White CJ, Hayward AR. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis. 1994 Sep; 170(3):522-6.
    View in: PubMed
    Score: 0.104
  4. Hayward AR, Zerbe GO, Levin MJ. Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods. 1994 Mar 29; 170(1):27-36.
    View in: PubMed
    Score: 0.101
  5. Hayward AR, Buda K, Levin MJ. Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults. Viral Immunol. 1994; 7(1):31-6.
    View in: PubMed
    Score: 0.100
  6. Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis. 1992 Aug; 166(2):253-9.
    View in: PubMed
    Score: 0.090
  7. Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD, Gershon AA, Sch?del F, Morrison VA, Kauffman CA, Straus SE, Schmader KE, Davis LE, Levin MJ. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis. 2009 Oct 01; 200(7):1068-77.
    View in: PubMed
    Score: 0.074
  8. Buda K, Tubergen DG, Levin MJ. The frequency and consequences of varicella exposure and varicella infection in children receiving maintenance therapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1996 May; 18(2):106-12.
    View in: PubMed
    Score: 0.029
  9. Levin MJ. Can herpes zoster be prevented? Eur J Clin Microbiol Infect Dis. 1996 Jan; 15(1):1-3.
    View in: PubMed
    Score: 0.029
  10. Levin MJ. Treatment and prevention options for respiratory syncytial virus infections. J Pediatr. 1994 May; 124(5 Pt 2):S22-7.
    View in: PubMed
    Score: 0.026
  11. Chiu C, McCausland M, Sidney J, Duh FM, Rouphael N, Mehta A, Mulligan M, Carrington M, Wieland A, Sullivan NL, Weinberg A, Levin MJ, Pulendran B, Peters B, Sette A, Ahmed R. Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV. PLoS Pathog. 2014 Mar; 10(3):e1004008.
    View in: PubMed
    Score: 0.025
  12. Somekh E, Levin MJ. Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine. J Med Virol. 1993 Jul; 40(3):241-3.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)